Schneider, H.; Hadj-Rabia, S.; Faschingbauer, F.; Bodemer, C.; Grange, D.K.; Norton, M.E.; Cavalli, R.; Tadini, G.; Stepan, H.; Clarke, A.;
et al. Protocol for the Phase 2 EDELIFE Trial Investigating the Efficacy and Safety of Intra-Amniotic ER004 Administration to Male Subjects with X-Linked Hypohidrotic Ectodermal Dysplasia. Genes 2023, 14, 153.
https://doi.org/10.3390/genes14010153
AMA Style
Schneider H, Hadj-Rabia S, Faschingbauer F, Bodemer C, Grange DK, Norton ME, Cavalli R, Tadini G, Stepan H, Clarke A,
et al. Protocol for the Phase 2 EDELIFE Trial Investigating the Efficacy and Safety of Intra-Amniotic ER004 Administration to Male Subjects with X-Linked Hypohidrotic Ectodermal Dysplasia. Genes. 2023; 14(1):153.
https://doi.org/10.3390/genes14010153
Chicago/Turabian Style
Schneider, Holm, Smail Hadj-Rabia, Florian Faschingbauer, Christine Bodemer, Dorothy K. Grange, Mary E. Norton, Riccardo Cavalli, Gianluca Tadini, Holger Stepan, Angus Clarke,
and et al. 2023. "Protocol for the Phase 2 EDELIFE Trial Investigating the Efficacy and Safety of Intra-Amniotic ER004 Administration to Male Subjects with X-Linked Hypohidrotic Ectodermal Dysplasia" Genes 14, no. 1: 153.
https://doi.org/10.3390/genes14010153
APA Style
Schneider, H., Hadj-Rabia, S., Faschingbauer, F., Bodemer, C., Grange, D. K., Norton, M. E., Cavalli, R., Tadini, G., Stepan, H., Clarke, A., Guillén-Navarro, E., Maier-Wohlfart, S., Bouroubi, A., & Porte, F.
(2023). Protocol for the Phase 2 EDELIFE Trial Investigating the Efficacy and Safety of Intra-Amniotic ER004 Administration to Male Subjects with X-Linked Hypohidrotic Ectodermal Dysplasia. Genes, 14(1), 153.
https://doi.org/10.3390/genes14010153
